...
search icon
abt-img

Abbott Laboratories Share Price

ABT
NYQ
$107.42
-$1.19
(-1.1%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Abbott Laboratories Analyst Forecast

Abbott Laboratories Share Price Chart

Abbott Laboratories Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$188.86B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
29.118
Volume info-icon
This is the total number of shares traded during the most recent trading day.
21.81M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
1.95%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.72
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$105.79 L
$138.63 H
$107.42

About Abbott Laboratories, Common Stock

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Abbott Laboratories Stock Returns

Time FrameABTSectorS&P500
1-Week Return-10.8%1.64%-0.4%
1-Month Return-12.79%2.13%0.14%
3-Month Return-14.03%8.39%2.61%
6-Month Return-13.69%16.16%8.7%
1-Year Return-11.86%9.86%13%
3-Year Return-4.74%17.8%72.1%
5-Year Return-5.33%33.74%79.31%
10-Year Return173.85%135.48%268.2%

Abbott Laboratories Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue34.61B43.08B43.65B40.11B41.95B[{"date":"2020-12-31","value":79.28,"profit":true},{"date":"2021-12-31","value":98.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.88,"profit":true},{"date":"2024-12-31","value":96.1,"profit":true}]
Cost of Revenue17.23B19.86B21.33B20.07B20.63B[{"date":"2020-12-31","value":80.78,"profit":true},{"date":"2021-12-31","value":93.11,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.1,"profit":true},{"date":"2024-12-31","value":96.69,"profit":true}]
Gross Profit17.38B23.21B22.32B20.04B21.32B[{"date":"2020-12-31","value":74.86,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.16,"profit":true},{"date":"2023-12-31","value":86.31,"profit":true},{"date":"2024-12-31","value":91.86,"profit":true}]
Gross Margin50.21%53.89%51.14%49.96%50.83%[{"date":"2020-12-31","value":93.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.89,"profit":true},{"date":"2023-12-31","value":92.7,"profit":true},{"date":"2024-12-31","value":94.33,"profit":true}]
Operating Expenses12.09B14.01B13.96B13.60B14.47B[{"date":"2020-12-31","value":83.5,"profit":true},{"date":"2021-12-31","value":96.82,"profit":true},{"date":"2022-12-31","value":96.46,"profit":true},{"date":"2023-12-31","value":93.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income5.29B9.20B8.36B6.43B6.83B[{"date":"2020-12-31","value":57.51,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.89,"profit":true},{"date":"2023-12-31","value":69.95,"profit":true},{"date":"2024-12-31","value":74.18,"profit":true}]
Total Non-Operating Income/Expense(823.00M)(1.48B)(431.00M)(19.00M)(27.00M)[{"date":"2020-12-31","value":-82300000000,"profit":false},{"date":"2021-12-31","value":-147900000000,"profit":false},{"date":"2022-12-31","value":-43100000000,"profit":false},{"date":"2023-12-31","value":-1900000000,"profit":false},{"date":"2024-12-31","value":-2700000000,"profit":false}]
Pre-Tax Income4.97B8.21B8.31B6.66B7.01B[{"date":"2020-12-31","value":59.81,"profit":true},{"date":"2021-12-31","value":98.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.23,"profit":true},{"date":"2024-12-31","value":84.43,"profit":true}]
Income Taxes497.00M1.14B1.37B941.00M(6.39B)[{"date":"2020-12-31","value":36.2,"profit":true},{"date":"2021-12-31","value":83.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.54,"profit":true},{"date":"2024-12-31","value":-465.33,"profit":false}]
Income After Taxes4.47B7.07B6.93B5.72B13.40B[{"date":"2020-12-31","value":33.36,"profit":true},{"date":"2021-12-31","value":52.76,"profit":true},{"date":"2022-12-31","value":51.73,"profit":true},{"date":"2023-12-31","value":42.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations4.47B7.07B6.93B5.16B13.40B[{"date":"2020-12-31","value":33.36,"profit":true},{"date":"2021-12-31","value":52.76,"profit":true},{"date":"2022-12-31","value":51.73,"profit":true},{"date":"2023-12-31","value":38.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations24.00M----[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income4.50B7.07B6.93B5.72B13.40B[{"date":"2020-12-31","value":33.54,"profit":true},{"date":"2021-12-31","value":52.76,"profit":true},{"date":"2022-12-31","value":51.73,"profit":true},{"date":"2023-12-31","value":42.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)3.655.215.344.444.67[{"date":"2020-12-31","value":68.35,"profit":true},{"date":"2021-12-31","value":97.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.15,"profit":true},{"date":"2024-12-31","value":87.45,"profit":true}]

Abbott Laboratories Ratios

Abbott Laboratories Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ABT
ROA (LTM) 6.79%
ROE (LTM) 30.62%

Abbott Laboratories Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ABT
Trailing PE 29.12
Forward PE 21.28
P/S (TTM) 4.31
P/B 4.12
Price/FCF 83
EV/R 4.91
EV/Ebitda 18.27
PEG 4.17

FAQs

What is Abbott Laboratories share price today?

Abbott Laboratories (ABT) share price today is $107.42

Can Indians buy Abbott Laboratories shares?

Yes, Indians can buy shares of Abbott Laboratories (ABT) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Abbott Laboratories be purchased?

Yes, you can purchase fractional shares of Abbott Laboratories (ABT) via the Vested app. You can start investing in Abbott Laboratories (ABT) with a minimum investment of $1.

How to invest in Abbott Laboratories shares from India?

You can invest in shares of Abbott Laboratories (ABT) via Vested in three simple steps:

  • Click on Sign Up or Invest in ABT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Abbott Laboratories shares
What is Abbott Laboratories 52-week high and low stock price?

The 52-week high price of Abbott Laboratories (ABT) is $138.63. The 52-week low price of Abbott Laboratories (ABT) is $105.79.

What is Abbott Laboratories price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Abbott Laboratories (ABT) is 29.118

What is Abbott Laboratories price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Abbott Laboratories (ABT) is 4.12

What is Abbott Laboratories dividend yield?

The dividend yield of Abbott Laboratories (ABT) is 1.95%

What is the Market Cap of Abbott Laboratories?

The market capitalization of Abbott Laboratories (ABT) is $188.86B

What is Abbott Laboratories's stock symbol?

The stock symbol (or ticker) of Abbott Laboratories is ABT

How Can Investors Use Abbott Laboratories Share Price Data for Long-Term Investment Decisions?

Consider the share price of Abbott Laboratories as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Abbott Laboratories has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Abbott Laboratories shares for Indian investors?

When investing in Abbott Laboratories shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Abbott Laboratories stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Abbott Laboratories share price with other stocks in the same sector?

Rather than merely checking the share price of Abbott Laboratories and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Abbott Laboratories stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top